Newborn screening for sickle cell disease through use of tandem mass spectrometry

Clinical Chemistry

Volumn 55, Issue 6, 2009, Pages 1243-1244

  Turner, Charles ^a   Daniel, Yvonne ^a   Dalton, R Neil ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN O; HEMOGLOBIN; HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN E; HEMOGLOBIN S; TRYPSIN; UNCLASSIFIED DRUG;

HEMOGLOBINOPATHY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LETTER; NEWBORN; NEWBORN SCREENING; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; TANDEM MASS SPECTROMETRY;

ANEMIA, SICKLE CELL; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; TANDEM MASS SPECTROMETRY;

EID: 66449084957     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.120964     Document Type: Letter

References (4)

1. Boemer F, Ketelslegers O, Minon JM, Bours V, Schoos R. Newborn screening for sickle cell disease using tandem mass spectrometry. Clin Chem 2008;54:2036-2041 (Pubitemid 352774037)
2. Daniel YA, Turner C, Haynes RM, Hunt BJ, Dalton RN. Rapid and specific detection of clinically significant haemoglobinopathies using electrospray mass spectrometry-mass spectrometry. Br J Haematol 2005;130:635-643 (Pubitemid 43899769)
3. 2 by tandem mass spectrometry. Clin Chem 2007;53:1448-1454
4. Daniel YA, Turner C, Farrar L, Dalton RN. A comparison of IEF and MSMS for clinical hemoglobinopathy screening in 40,000 newborns. From: 50th American Society of Hematology annual meeting; 2008 Dec 6-9; San Francisco. http:// ash.confex.com/ash/2008/webprogram/Paper9728. html (Accessed November 2008).